Model N Acquires Kalderos, Looks to Expand its 340B Capabilities

Model N Kalderos logo
Model N, an end-to-end commercialization, revenue optimization and compliance platform for life sciences companies, announced it had acquired Kalderos on June 17.
A California-based cloud software company has acquired Kalderos, a health technology company and drug industry vendor that’s been a key [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

BI 12th Drugmaker to Require In-House Claims Data

BI logo
Boehringer Ingelheim will require all 340B covered entities to submit pharmacy and medical claims data on all dispenses, including at in-house pharmacies, beginning July 6.
German drugmaker Boehringer Ingelheim (BI) will require all 340B covered entities to submit pharmacy and medical claims data on all [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

GOP Critics Take Another Swipe at 340B After Fox News Highlights Fla. Fraud Case

Fox News screenshot
The GOP leaders of congressional committees tasked with overseeing the 340B program renewed their calls for reform this week after Fox News Digital—and other conservative-leaning outlets—reported that a Haitian citizen and two U.S. citizens submitted $58 million in fraudulent 340B drug claims. 
The Republican leaders of congressional committees tasked with overseeing the 340B program renewed their calls for reform this week after [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Novartis Exempts Wash. from CP Restrictions, Bans Alt. Distribution Models

Novartis logo on building
Novartis has updated its 340B contract pharmacy restrictions policy to exempt Washington state hospitals and prohibit covered entities’ use of alternative distribution models.
A Swiss pharmaceutical giant recently updated its 340B contract pharmacy restrictions policy to exempt Washington state hospitals and prohibit covered [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

CMS Looks to Crack Down on Medicare Drug Price Negotiation Loophole

A new CMS proposed rule would codify the MDPNP and end a practice that allows drugmakers that modify their products to avoid being subject to negotiation.
Federal health officials last week released a proposal that would codify the federal Medicare Drug Price Negotiation Program (MDPNP) beginning [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Three Drugmakers Exempt New States from Contract Pharmacy, Claims Data Policies

Sobi, BMS, Novo Nordisk logos
Sobi, BMS and Novo Nordisk recently updated state exemptions to their 340B contract pharmacy restriction and claims data requirements.
Three drugmakers recently updated their 340B contract pharmacy restriction and claims data requirements to comply with various state contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Premier, Hospitals Laud HRSA’s Move to Not Appeal Ruling that Struck Down Drug Purchasing Restrictions Policy

Premier logo outside building
Premier and and hospital advocates lauded HRSA's decision to not appeal a federal court ruling that struck down a 2013 policy restricting how certain 340B hospitals can purchase initial drug inventory.
One of the country’s largest group purchasing organizations (GPO) and hospital advocates this week lauded federal health officials’ decision to [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Critics Briefly Mention 340B at House E&C Hearing on Healthcare Costs

Auchincloss speaks at a hearing.
U.S. Rep. Jake Auchincloss (D-Mass.) asked the head of a national healthcare purchaser group and a Brown University professor, who have both been critical of the 340B program, for input on how Congress should address 340B issues.
The head of a national healthcare purchaser group and a Brown University professor, who have both been critical of the [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Longtime PhRMA Executive Who Played Key Role on 340B Issues to Join AbbVie in September

Lori Reilly testifies in Congress.
PhRMA COO Lori Reilly announced on June 1 that she will join AbbVie as its senior vice president for government affairs in September.
A top PhRMA executive, who’s been a major force on Capitol Hill on 340B issues for over two decades, announced [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

HRSA Does Not Appeal Ruling that Struck Down 340B Hospital Drug Purchasing Restrictions Policy

Premier logo on a sign
The Trump administration did not appeal a Washington D.C. federal court’s late-March ruling that struck down a 2013 HRSA policy restricting how certain 340B hospitals can purchase initial drug inventory.
The Trump administration did not appeal a Washington D.C. federal court’s late-March ruling that struck down a 2013 HRSA policy [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live

; ?>